Acorn Campus Ventures

Acorn Campus Ventures, founded in 2000, is a venture capital firm headquartered in Santa Clara, California, with additional offices in New York and Shanghai. The firm specializes in incubation, seed, and early-stage investments, primarily targeting the technology sector. Acorn Campus Ventures focuses on industries such as wireless communications, semiconductors, photonics, internet services, and life sciences. The firm aims to support emerging companies by providing investments of up to $3 million, with a particular interest in opportunities within China. Through its strategic investments, Acorn Campus Ventures seeks to foster innovation and growth in these dynamic sectors.

David Tsang Ph.D

Partner

T. Chester Wang Ph.D

Co-Founder and Managing Partner

Hsing Kung Ph.D

Managing Partner

15 past transactions

Flat Medical

Series A in 2017
Flat Medical specializes in developing safety technology solutions aimed at enhancing clinical processes. The company's innovative technology is designed for use during surgical procedures, where it plays a crucial role in detecting and preventing surgical mistakes. By doing so, Flat Medical enables clinical professionals to provide safer treatment options for their patients, thereby improving overall patient safety and care quality.

Eureka Therapeutics

Series C in 2014
Eureka Therapeutics, Inc. is a biotechnology company specializing in immunotherapies for cancer treatment. Founded in 2006 and located in Emeryville, California, the company focuses on developing antibody-TCR (AbTCR) and T-cell therapies aimed at solid tumors and hematological malignancies. Eureka has created the ARTEMIS AbTCR T-cell receptor platform and the E-ALPHA antibody discovery platform, the latter being one of the largest human-derived antibody phage libraries, which generates target-specific antibodies, including T cell receptor-mimic antibodies against intracellular targets. The company targets cancer-specific antigens, onco-fetal antigens, mutated oncogenes, and viral oncogenes. To enhance its research capabilities, Eureka Therapeutics has established a strategic collaboration with Lyell Immunopharma, aiming to improve the safety profile of T-cell therapies and develop novel treatments for cancer.

Waterstone Pharmaceuticals

Series B in 2012
Waterstone Pharmaceuticals, Inc. is a private company focused on the research, development, and commercialization of innovative drugs for liver, gastrointestinal, kidney, and metabolic diseases. Founded in 2009, the company has its headquarters in Wuhan, China, with additional offices in Tianmen. Waterstone's activities encompass drug discovery, the development of proprietary new chemical entities, custom development and manufacturing services, and the production of generic drugs. The company also specializes in creating a range of active pharmaceutical ingredients, intermediates, and antibody drug conjugates.

Eureka Therapeutics

Series B in 2008
Eureka Therapeutics, Inc. is a biotechnology company specializing in immunotherapies for cancer treatment. Founded in 2006 and located in Emeryville, California, the company focuses on developing antibody-TCR (AbTCR) and T-cell therapies aimed at solid tumors and hematological malignancies. Eureka has created the ARTEMIS AbTCR T-cell receptor platform and the E-ALPHA antibody discovery platform, the latter being one of the largest human-derived antibody phage libraries, which generates target-specific antibodies, including T cell receptor-mimic antibodies against intracellular targets. The company targets cancer-specific antigens, onco-fetal antigens, mutated oncogenes, and viral oncogenes. To enhance its research capabilities, Eureka Therapeutics has established a strategic collaboration with Lyell Immunopharma, aiming to improve the safety profile of T-cell therapies and develop novel treatments for cancer.

Innolight

Series A in 2008
InnoLight Technology is a prominent supplier of high-speed optical transceivers based in China, specializing in the research, design, manufacture, and marketing of advanced optical modules, including 10G, 40G, and 100G products. The company focuses on creating high-performance optical transceivers characterized by large capacity, compact size, low power consumption, and cost-effectiveness. These optical interconnect solutions cater to a variety of sectors, including cloud computing, data centers, data communication, long-distance transmission, and wireless access. InnoLight's value lies in its cutting-edge optical component technology, expertise in high-speed module design, and unique testing capabilities, which enhance efficiency and productivity for its clients. Founded in April 2008, InnoLight aims to merge Silicon Valley's technological advancements with the talents and market potential of China, aspiring to establish itself as a world-class provider of high-end optical modules.

Autekbio

Series A in 2007
Sino-US AutecBio Inc. (中美奥达有限公司) is a biotechnology company offering contract research and manufacturing services for biopharmaceutical and biotech companies in the United States, China, and internationally. The company owns unique molecular and cellular biological technologies, large-scale mammalian cell culture technologies, protein purification technologies, and corresponding analysis testing technologies. With a technology and production platform of proprietary intellectual property rights, the company integrates research and development with the production of contracts, takes advantages of foreign advanced and mature biological technologies, and improves the level of the domestic pharmaceutical industry and production industry of biological products. Sino-US AutecBio was founded in Silicon Valley, USA.

Optovue

Series B in 2007
Optovue, Inc. is an ophthalmic device company based in Fremont, California, specializing in the design, development, manufacturing, and sale of spectral-domain optical coherence tomography (OCT) devices. Founded in 2003, the company focuses on creating advanced imaging modalities to enhance the diagnosis and treatment of ocular diseases. Its product portfolio includes the AngioVue system for visualizing retinal vasculature, the Avanti device for assessing peripheral retina pathology, and the iFusion platform that integrates OCT with fundus imaging. Additional offerings include iVue for retinal and corneal assessments, NetVue for cloud image management, and AngioAnalytics for measuring blood vessels to aid in managing diseases leading to vision loss. Optovue's technology provides high-resolution imaging capabilities, enabling eye care professionals and researchers to improve clinical outcomes for conditions such as macular degeneration, diabetic retinopathy, and glaucoma. The company also offers customer support and online resources to assist users in leveraging its technologies effectively.

Qpixel Technology

Series B in 2006
Qpixel Technology operates as a fabless semiconductor company which provides video compression silicon and software solutions. It develops audio/video compression silicon solutions for digital consumer electronics devices, such as digital cameras and camcorders, set top boxes/PVRs/DVRs and remote monitoring devices, and IP video communications devices. The company's product suite includes standard and high definition codecs with on-chip audio DSP; and design kit, including boards, firmware, and design files for original equipment manufacturer time-to-production. Qpixel Technology, Inc. was founded in 2003 and is headquartered in Cupertino, California with engineering and sales offices in Taiwan and Japan.

Qpixel Technology

Series A in 2004
Qpixel Technology operates as a fabless semiconductor company which provides video compression silicon and software solutions. It develops audio/video compression silicon solutions for digital consumer electronics devices, such as digital cameras and camcorders, set top boxes/PVRs/DVRs and remote monitoring devices, and IP video communications devices. The company's product suite includes standard and high definition codecs with on-chip audio DSP; and design kit, including boards, firmware, and design files for original equipment manufacturer time-to-production. Qpixel Technology, Inc. was founded in 2003 and is headquartered in Cupertino, California with engineering and sales offices in Taiwan and Japan.

Fortinet

Series E in 2004
Fortinet is a cybersecurity company based in California that specializes in network security appliances and a comprehensive range of security solutions, including cloud security, zero-trust access, and security operations. The company serves a diverse clientele, including enterprises, managed service providers, and telecommunications carriers, and is known for its ability to deliver high levels of security while minimizing total ownership costs. With over 700,000 customers globally, Fortinet primarily generates revenue through its subscription and support services, providing a flexible and scalable path for expansion in the ever-evolving cybersecurity landscape.

Optovue

Series A in 2004
Optovue, Inc. is an ophthalmic device company based in Fremont, California, specializing in the design, development, manufacturing, and sale of spectral-domain optical coherence tomography (OCT) devices. Founded in 2003, the company focuses on creating advanced imaging modalities to enhance the diagnosis and treatment of ocular diseases. Its product portfolio includes the AngioVue system for visualizing retinal vasculature, the Avanti device for assessing peripheral retina pathology, and the iFusion platform that integrates OCT with fundus imaging. Additional offerings include iVue for retinal and corneal assessments, NetVue for cloud image management, and AngioAnalytics for measuring blood vessels to aid in managing diseases leading to vision loss. Optovue's technology provides high-resolution imaging capabilities, enabling eye care professionals and researchers to improve clinical outcomes for conditions such as macular degeneration, diabetic retinopathy, and glaucoma. The company also offers customer support and online resources to assist users in leveraging its technologies effectively.

Fortinet

Series D in 2003
Fortinet is a cybersecurity company based in California that specializes in network security appliances and a comprehensive range of security solutions, including cloud security, zero-trust access, and security operations. The company serves a diverse clientele, including enterprises, managed service providers, and telecommunications carriers, and is known for its ability to deliver high levels of security while minimizing total ownership costs. With over 700,000 customers globally, Fortinet primarily generates revenue through its subscription and support services, providing a flexible and scalable path for expansion in the ever-evolving cybersecurity landscape.

RASILIENT SYSTEMS

Series A in 2003
RASILIENT Systems, Inc. specializes in video surveillance storage platforms and system software, offering innovative storage technologies designed for system integrators and OEM customers. Their flagship product is a 2U/12 bay storage appliance tailored specifically for video surveillance applications. The company emphasizes advanced caching and patented technologies that minimize data loss, ensuring complete reliability and performance in video surveillance storage, viewing, and administration. Founded in 2001, RASILIENT Systems is headquartered in Sunnyvale, California, and has development centers in California, Shanghai, and Taipei, allowing it to serve a global clientele effectively.

Luxnet

Venture Round in 2001
LuxNet Corporation specializes in the design, development, and manufacturing of optical semiconductor devices and packaged optical components, primarily based in Taoyuan City, Taiwan. Founded in 1999, the company produces a range of products, including laser and photodiode chips, transmitters, receivers, and optical sub-assemblies. These components facilitate high-speed voice, video, and data communications across various applications, such as networking, storage, and cable television. In addition to its core manufacturing activities, LuxNet is also involved in the processing and sale of electronic components and active components for optical communication. Its operations extend beyond Taiwan to include markets in China and the United States.

Leopard Logic

Series A in 2001
Leopard Logic is a fabless semiconductor company specializing in the design and development of embedded programmable logic solutions. The company offers configurable logic devices that enhance performance, lower power consumption, and reduce board space and costs. These devices are versatile and applicable across a range of markets, including networking, storage, and wireless applications, where flexible logic solutions are essential.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.